Rib-X seeks public listing

Infectious disease company Rib-X Pharmaceuticals Inc. (New Haven, Conn.) filed to raise up to $80 million in an IPO underwritten by Deutsche Bank; William Blair; Lazard; and Needham. Rib-X's delafloxa...